|
Real-time Estimate
Cboe BZX
17:58:35 24/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 439.91 USD | +0.13% |
|
+5.19% | +34.77% |
| 08-21 | FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case | DJ |
| 08-20 | Piper Sandler Adjusts Price Target on Amgen to $457 From $427, Maintains Overweight Rating | MT |
Transcripts
Search
No results match your criteria
- Stock Market
- Stocks
- AMGN Stock
- News Amgen Inc.
- Transcripts
Select your edition
All financial news and data tailored to specific country editions
















